v3.26.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
3 Months Ended 12 Months Ended
Jun. 06, 2025
USD ($)
Mar. 31, 2026
USD ($)
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Aug. 05, 2025
USD ($)
Oct. 22, 2021
USD ($)
Accounts Receivable, Allowance for Credit Loss, Current   $ 700,000   $ 700,000    
Credit Loss Expense   0 $ 37,000      
Inventory Valuation Reserves   0   0    
Number of Patents Acquired           3
Intangible Asset, Excluding Goodwill, after Accumulated Amortization           $ 34,000
Contract with Customer, Liability, Current   319,000   280,000    
Customer Deposit Liability, Current   188,000   189,000    
Unrecognized Tax Benefits   0   $ 0    
Operating Lease, Weighted Average Discount Rate, Percent       18.00%    
Operating Lease, Right-of-Use Asset   979,000   $ 1,028,000    
Operating Lease, Liability   1,027,000   1,074,000    
Finance Lease, Right-of-Use Asset, after Accumulated Amortization   310,000   338,000    
Clyra Medical Technologies [Member]            
Finance Lease, Right-of-Use Asset, after Accumulated Amortization   310,000   338,000    
Finance Lease, Liability   $ 336,000   $ 360,000    
Subsidiary, Ownership Percentage, Noncontrolling Owner   52.00%   52.00%    
BioLargo Engineering, Science & Technologies, LLC [Member]            
Subsidiary, Ownership Percentage, Noncontrolling Owner   30.00%   30.00%    
BioLargo Energy Technologies, Inc (BETI) [Member]            
Subsidiary, Ownership Percentage, Noncontrolling Owner   7.00%   5.00%    
Minimum [Member]            
Property, Plant and Equipment, Useful Life (Year)   3 years        
Maximum [Member]            
Property, Plant and Equipment, Useful Life (Year)   10 years        
Canadian Government Grants [Member] | Minimum [Member]            
Grant Term (Month)       6 months    
Canadian Government Grants [Member] | Maximum [Member]            
Grant Term (Month)       18 months    
ONM [Member]            
Customer Deposit Liability, Current   $ 109,000   $ 109,000    
CANADA            
Customer Deposit Liability, Current   $ 79,000   80,000    
Share-Based Payment Arrangement, Option [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares   68,311,167        
Warrant [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares   32,217,910        
Royalty Receivable [Member]            
Financing Receivable, before Allowance for Credit Loss         $ 463,520  
Pooph Inc. Receivable [Member]            
Credit Loss Expense       $ 3,886,000    
Financial Asset, Past Due [Member] | Product Invoice Receivable [Member]            
Financing Receivable, before Allowance for Credit Loss $ 2,385,468          
Receivable with Imputed Interest, Effective Yield (Interest Rate) 10.00%          
Financial Asset, Past Due [Member] | Royalty Receivable [Member]            
Financing Receivable, before Allowance for Credit Loss $ 1,378,141